Dr. Nicole Saphier sat before the Senate health committee this week and said the things a surgeon general nominee is supposed to say. "I do not believe the MMR vaccine to be lethal," she told senators. "I believe the MMR vaccine is our greatest tool for combatting measles." And on the claim that has done the most damage to vaccination rates in recent years, she was direct: "I do not believe childhood vaccines cause autism."
Then the hearing got to the part that matters, and it was the chair who forced it there. Senator Bill Cassidy pressed Saphier, a physician himself, to state the science not as a personal belief but as settled fact. The distance between "I believe" and "the evidence shows" turned out to be the central subject of the hearing. It is also, in some ways, the entire job description of the office she is seeking.
The vacancy the nominee would fill
The surgeon general's post has been vacant for the entirety of the current administration. The first nominee, Janette Nesheiwat, was withdrawn over questions about her academic credentials. The second, Casey Means, stalled in the Senate over her background and public vaccine commentary. Saphier is the third attempt, a radiologist and director of breast imaging at Memorial Sloan Kettering Monmouth who is also a former Fox News contributor and the author of a 2020 book titled "Make America Healthy Again."
That biography made her confirmation hearing unusual from the start. Saphier has publicly disagreed with administration figures on health policy before, calling a presidential warning about Tylenol in pregnancy "oversimplistic" and "patronizing," criticizing what she described as a flawed MAHA report, and describing the health secretary's firing of a CDC director as "a mess." Nominees are normally screened for loyalty to the administration's positions. This one arrived with a public record of pushing back, which gave senators on both sides reasons to probe rather than to predict.
What the measles outbreak did to the room
The hearing took place against the worst measles year in the United States in decades. A Pennsylvania outbreak has grown to 731 cases, including four deaths, all among unvaccinated people. Measles is one of the most contagious viruses known, and declining public confidence in the MMR vaccine is the reason outbreaks that once ended in days now spread through communities for months.
That backdrop put a specific question to the nominee. The health secretary has repeatedly questioned vaccine guidance and has suggested the MMR vaccine can be harmful, comments that public health officials say run against decades of evidence. Cassidy made the stakes explicit, calling the measles deaths "a terrible legacy for this administration" and criticizing what he called irresponsible health policy leadership. A surgeon general nominated by this administration, in front of this committee, during this outbreak, could not treat the vaccine question as hypothetical.
Saphier's answers on MMR were unambiguous in substance. But when Cassidy asked her to state the science as fact rather than belief, she framed her answers as convictions. The distinction is not wordplay. Public health agencies exist to speak for the evidence, not for the person holding the office. A surgeon general who says "I believe" has answered as a witness. A surgeon general who says "the evidence shows" has answered as the office.
Where she stopped short
On hepatitis B, the hearing found its boundary. Saphier called the universal birth dose safe and effective but declined to say it should be universally recommended, and declined to say the administration's shift to shared clinical decision-making should be reversed. Shared decision-making sounds like patient empowerment, but in vaccination policy it has a specific effect: it removes the standing recommendation that drove uptake. Critics argue the change quietly reduces vaccination without saying so. The nominee's refusal to disavow it, even while calling the dose safe and effective, left the administration's policy intact and her own position harder to pin down.
She was clearer on institutional questions. Asked what she would do if ordered to take an unlawful action, she said she has "no intention of breaking the law," and she pledged to work to restore public trust in the office she hopes to hold.
The other nominee in the room
The hearing also covered Chris Klomp, the nominee for deputy secretary of Health and Human Services, who told senators the country needs a clear definition of measles-associated deaths and that promoting measles vaccination should be a priority, and Timothy Westlake, the nominee for assistant secretary for mental health and substance use. Klomp's nomination matters because the deputy secretary runs the department's operations while the secretary sets its direction. A deputy who publicly endorses measles vaccination would sit one layer below a secretary whose public statements have moved in the opposite direction.
That tension, more than any single answer, is what the hearing exposed. The administration's nominees are being asked to defend vaccination policy to a committee that sees an outbreak as the consequence of that policy. The nominees' answers have been more supportive of vaccines than the administration's public posture. Whether the Senate reads that as reassurance or as evidence that the policy itself is the problem will decide the vote.
What the surgeon general's office is for
The office Saphier is seeking is small in staff and enormous in reach. The surgeon general leads the U.S. Public Health Service Commissioned Corps, but the role's real power is the authority to speak. Past holders of the office have used it to change national behavior, on smoking, on HIV, on opioids. The office's effectiveness rests on a compact with the public: the person in the job speaks for the evidence, and when the evidence changes, the position changes.
That compact is what made the "I believe" formulation matter in the hearing room. A surgeon general's statements are not personal testimony. They are public health guidance wearing the uniform of the office. When the person holding the office frames scientific conclusions as personal convictions, the office itself becomes a voice among voices, one more opinion in a debate that already has too many. The committee was not quibbling over phrasing. It was asking whether the nominee understands what the office is.
The vacancy has made the question practical rather than theoretical. For more than a year there has been no surgeon general to speak for the evidence during a period of active public debate over vaccines. The absence itself has been a statement. Confirmation would end the vacancy; it would not, by itself, restore the compact.
The measles math that sat over the hearing
Measles is the most contagious disease known to public health, roughly nine times more transmissible than influenza, and it finds every pocket of unvaccinated people with a patience that slower-spreading viruses do not have. Public health officials describe herd immunity for measles as requiring about 95 percent vaccination coverage. The Pennsylvania outbreak's 731 cases sit inside a national decline in childhood MMR uptake, driven in part by the contested autism claim that Saphier was asked to address directly.
The four Pennsylvania deaths are the reason the hearing had the gravity it did. Measles deaths in the United States had become rare events, and each one is preventable with a vaccine that has been in routine use for decades. The epidemiology does not care about anyone's politics, and the committee knew it: whatever one thinks of the administration's vaccine policy, the outbreak is the policy's measurable consequence, and the deaths are its cost.
Saphier's testimony, read against that backdrop, was the most pro-vaccine statement any administration nominee has made this term. The MMR vaccine is safe, it is the greatest tool against measles, and it does not cause autism. Those are the positions the public health community has held for years, stated plainly by a nominee whose administration has often stated them less plainly or not at all. The hearing's unresolved question is whether the statement carries more weight coming from her, when the office she seeks has spent a year standing empty.
What confirmation would and would not change
A surgeon general leads the U.S. Public Health Service Commissioned Corps and speaks with the authority of the office on health emergencies. The position is influential precisely because it is seen as speaking for science rather than for politics, which is why the vacancy has mattered for more than a year.
Confirmation of a nominee who affirms the MMR vaccine would change the voice coming from the office. It would not, by itself, change the vaccine guidance issued by the department, the ordering decisions at the CDC, or the public statements of the secretary. Those are the mechanisms that actually move vaccination rates. The hearing asked whether Saphier would be a credible voice inside them. Her answers suggested she would say what she believes. The question the committee now has to answer is whether, in this administration, during this outbreak, belief is enough.
Primary sources
- CIDRAP for the hearing testimony, the exchange with Senator Cassidy, and the nominee's vaccine statements.
- Fierce Healthcare for the Pennsylvania outbreak figures and the nominees questioned alongside Saphier.
- NPR for the background on the two prior nominees and the administration's vaccine-policy record.
- FOX News for the nominee's statements on the MMR vaccine and autism.